Can I give meropenem twice daily (bid) for a patient with normal renal function and a serious gram‑negative infection?

No, meropenem should NOT be given twice daily (BID) for serious gram-negative infections in patients with normal renal function

The FDA-approved dosing for meropenem in adults with normal renal function is every 8 hours (three times daily), not twice daily. 1

Standard Dosing Requirements

For patients with creatinine clearance >50 mL/min:

• Complicated skin/skin structure infections: 500 mg IV every 8 hours
• Complicated intra-abdominal infections: 1 gram IV every 8 hours
• Pseudomonas aeruginosa infections: 1 gram IV every 8 hours 1

BID (every 12 hours) dosing is only appropriate when creatinine clearance is 26-50 mL/min - this represents renal impairment, not normal function 1.

Why Every 8 Hours Matters

Meropenem is a time-dependent beta-lactam antibiotic. Its efficacy depends on maintaining drug concentrations above the pathogen's minimum inhibitory concentration (MIC) for a sufficient percentage of the dosing interval.

• The pharmacodynamic target is typically 40% time above MIC (40% ƒT>MIC) for standard infections
• More aggressive targets of 100% ƒT>MIC may be needed for critically ill patients or resistant organisms 2

Extending the dosing interval from every 8 hours to every 12 hours in patients with normal renal function creates prolonged periods where drug levels fall below therapeutic thresholds, particularly for less susceptible organisms 3, 4.

Clinical Evidence Against BID Dosing

Monte Carlo simulations demonstrate that:

• Standard every 8-hour dosing achieves 100% probability of target attainment against most Gram-negative pathogens with normal susceptibility 3
• For organisms with higher MICs (like some Pseudomonas or Acinetobacter), even every 8-hour dosing may be insufficient without extended infusions 4
• Reducing frequency to every 12 hours would dramatically decrease the probability of achieving pharmacodynamic targets 5, 2

Optimization Strategies (Not BID)

If you're concerned about dosing convenience or optimization in serious infections with normal renal function, consider:

1. Extended infusions: Administer the same every-8-hour dose over 3 hours instead of 30 minutes - this maintains higher trough concentrations 6, 3, 4

2. Continuous infusion: After a loading dose, give the total daily dose as a continuous infusion (e.g., 3-6 grams/24 hours) - this provides superior target attainment against resistant organisms 3, 7

3. Increased frequency: For augmented renal clearance in critically ill patients, some may require dosing every 6 hours, not less frequently 2

Common Pitfall

Do not confuse "normal renal function" with "renal impairment." The every-12-hour dosing you may have seen applies only to patients with CrCl 26-50 mL/min. Using BID dosing in patients with normal kidneys risks treatment failure, particularly with serious infections caused by less susceptible organisms 1, 4.